European Journal of Paediatric Neurology

Papers
(The TQCC of European Journal of Paediatric Neurology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Editorial88
Associations between muscle morphology and spasticity in children with spastic cerebral palsy45
Motor imagery ability of children with duchenne muscular dystrophy: Reliability and validity of kinesthetic and Visual Imagery Questionnaire-10, and its association with cognitive status40
The utility of creatine kinase in status dystonicus and pre-status dystonicus28
A life course perspective on mental disorders and psychopharmacologic drug use among persons living with cerebral palsy26
Spinal cord stimulation (SCS) induced favorable neuromodulative outcome in the treatment of chronic neuropathic pain syndrome in children26
Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review24
Autoimmune encephalitis in Israeli children – A retrospective nationwide study24
Urgent unmet need for pharmaceutical grade vitamin therapy in pyridoxine dependent epilepsies24
‘Focal Seizures in Dystonic Cerebral Palsy (DCP): Rare or common or both?23
Analysis of the relation between cerebrospinal fluid antibody titers and clinical characteristics in pediatric patients with anti-N-methyl-D-aspartate receptor encephalitis23
Pediatric varicella zoster virus associated arterial ischemic stroke – A post-pandemic rise in incidence in Denmark20
CSF IL-6 in pediatric neuroinflammation: Diagnosing disease or driving therapy?20
Treatment response in children with relapsing MOG-antibody associated disease19
Is late diagnosis of Duchenne muscular dystrophy still a reality?18
Disruptive lesions can cause developmental anomalies in the fetal brain: Mini-review18
Clinical presentation, MR imaging and outcome in children with myelin oligodendrocyte glycoprotein antibody-negative acute disseminated encephalomyelitis17
Quality of life in young adolescents with epilepsy: A case control study17
Acute seizures and the risk of post-stroke epilepsy in children with arterial ischemic stroke16
Unmet health care needs over the first 2 years after pediatric traumatic brain injury15
Identification of novel pathogenic variants in the GCDH gene and assessment of neurodevelopmental outcomes in 24 children with glutaric aciduria type 115
Genetic causes of infection induced encephalitis15
The added value of multimodal neurophysiological tools in the prognostic assessment of perinatal hypoxic-ischemic encephalopathy15
Dysmature patterns of newborn EEG recordings: Biological markers of transitory brain dysfunction or brain injury15
From childhood to adulthood: Long-term assessment of continuous intrathecal baclofen therapy in non-ambulant spastic cerebral palsy15
“Fidgety-like movements” in extremely preterm infants - A new entity of spontaneous movements15
Comparison of clinical characteristics between cluster and isolated seizures associated with benign convulsions with mild gastroenteritis15
Behavioral problems in infants and young children with spinal muscular atrophy and their siblings: A cross-sectional study14
The development of checklists and reference charts for activities of daily living of normal developing children14
Migraine and epilepsy: Social cognition skills in pediatric population13
Opioid analgesia and temperature regulation are associated with EEG background activity and MRI outcomes in neonates with mild-to-moderate hypoxic-ischemic encephalopathy undergoing therapeutic hypoth13
Assessing communication, beyond just words12
GLUT1DS focus on dysarthria12
Cost-effective diagnosis for children with developmental and epileptic encephalopathy phenotype12
CSF IL-6 in children with neuroinflammatory conditions12
Outcome measurement instruments in Rett syndrome: A systematic review12
Respiratory function in LAMA2-related muscular dystrophy and SELENON-related congenital myopathy, a 1.5-year natural history study12
Developmental neurobiology of cerebellar and Basal Ganglia connections12
Cost-effectiveness of whole-exome sequencing in progressive neurological disorders of children12
Fatigue, depression, and health-related quality of life in pediatric-onset multiple sclerosis: A comparative study from a tertiary care center12
Gene therapy offers promise, but timing is crucial for SMA treatment12
Genotype variability in early-onset Hereditary Spastic Paraplegia: a single-center study11
Tumefactive demyelinating lesions: navigating the many faces of mimicry11
Insights from European Reference Network for rare neurological disorders study surveys on diagnosis, treatment, and management of NKX2-1-related disorders11
Experience of nusinersen treatment in advanced spinal muscular atrophy type 1: Characteristics of late responders with delayed treatment efficacy11
Exploring the connections between basal ganglia and cortex revealed by transcranial magnetic stimulation, evoked potential and deep brain stimulation in dystonia10
Ultra-rare ultra-care: Assessing the impact of caring for children with ultra rare diseases10
Plant-derived cannabinoids for treatment of spasticity in children and adolescents with severe cerebral palsy: Double-blind, placebo-controlled trial10
Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromes10
Dystonia during hand activity in children with spastic unilateral cerebral palsy, an observational study10
Pediatric Neurotuberculosis: A cases series and review of the literature10
Sphenoid dysplasia in patients with neurofibromatosis type 1: Clinical features and imaging findings including cerebrospinal fluid alterations10
Piloting positive psychology resources for caregivers of a child with a genetic developmental and epileptic encephalopathy10
Genotype – phenotype correlation of Spinal Muscular Atrophy in the era of disease modifying therapies: A tertiary Indian experience10
Letter to the Editor in response to Dr. Josef Finsterer et al. “Intense work-up is required for pediatric COVID-related acute necrotizing encephalopathy with RANBP2 variants”10
CSF-profile and hypocretin levels in children with narcolepsy type 1 and 210
The association of serum vitamin D concentrations in paediatric migraine10
Behavioral, neurodevelopmental profile, and epilepsy trajectory in two series of SLC6A1-NDD: A retrospective study with comprehensive assessment, and a participatory database study10
The promise of personalized medicine in pediatric epilepsy – The time has come9
Vertigo, pediatric migraine, and best treatment9
Clinical correlation between disease progression and central vein sign in pediatric onset multiple sclerosis: A binational study9
It's easier to relearn gross motor skills than learn them for the first time after injury: Empirical evidence informing the age at injury debate9
The choroid plexus as a diagnostic tool in Sturge-Weber syndrome9
Frequency of an intrathecal IgM synthesis and MRZ reaction in children with MS9
Editorial Board9
Newborn screening in metachromatic leukodystrophy – European consensus-based recommendations on clinical management9
Folker Hanefeld, 1937–20229
Fat embolism syndrome in Duchenne muscular dystrophy: Report on a novel case and systematic literature review9
Temporal trends in intraventricular hemorrhage in preterm infants: A Brazilian multicenter cohort9
Prognostic significance of ACTN3 genotype in Duchenne muscular dystrophy: Findings from an Argentine patient cohort8
Intense work-up is required for pediatric COVID-related acute necrotizing encephalopathy with RANBP2 variants8
Similar disease progression in nonsense Duchenne muscular dystrophy boys as general natural history: Single Brazilian center 15 years registry view8
Mid- and long-term (at least 12 months) follow-up of patients with spinal muscular atrophy (SMA) treated with nusinersen, onasemnogene abeparvovec, risdiplam or combination therapies: A systematic rev8
Health-related quality of life in 153 children with neuromuscular disorders in Latin America: is it age, functional dependence or diagnosis?8
Movement disorders, cerebral palsy and vaccination8
Limb girdle muscular dystrophies: striving to bridge a diagnostic gap8
Reliability and validity of a newly developed PANDAS/PANS questionnaire8
Provoked seizures might lead to a significant diagnosis delay in CLN28
Comprehensive neurological evaluation of a cohort of patients with neurofibromatosis type 1 from a single institution8
Determinants of long-term health-related quality of life in paediatric traumatic brain injury8
Pathological gait in Rett syndrome: Quantitative evaluation using three-dimensional gait analysis8
Is ketogenic diet a ‘precision medicine’? Recent developments and future challenges7
Frequency and clinical relevance of MOG-antibodies in CSF in pediatric patients with MOG antibody-associated diseases7
Are atypical knee jerk responses prognostic for cerebral palsy in high-risk infants and children?7
Visual outcome measures in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)7
Optimising patient care, expectations and experiences: Healthcare providers’ experiences of delivering sleep medicine services within an Australian tertiary paediatric facility7
Bradykinesia assessment in children with cerebral palsy and periventricular leukomalacia7
Harmful metabolic acidosis in children treated by ketogenic diet during prolonged general anesthesia for epilepsy surgery: A single center experience7
Neuro-developmental outcomes in infants with vitamin B12-deficiency and neurologic features7
Autonomic risks in Alternating Hemiplegia of Childhood7
Deep brain stimulation for phantom limb pain7
Vaccination and childhood epilepsies7
“Deconstructing” upper limb function in dyskinetic cerebral palsy7
Predicting respiratory failure and outcome in pediatric Guillain-Barré syndrome7
Neurophysiological recordings improve the accuracy of the evaluation of the outcome in perinatal hypoxic ischemic encephalopathy7
Ocrelizumab in pediatric patients with MS: Efficacy, tolerability, and safety7
Outcomes for patients in the RESTORE registry with spinal muscular atrophy and four or more SMN2 gene copies treated with onasemnogene abeparvovec7
Reduced elbow muscle strength in children and adolescents with Charcot-Marie-Tooth disease: a case control study6
Starting a DBS service for children: It’s not the latitude but the attitude - Establishment of the paediatric DBS centre in Northern Finland6
Advances in genetics: The start of a new stage for management of focal cortical malformations6
Myotonic dystrophy type 1 (Steinert disease): 29 years of experience at a tertiary pediatric hospital6
Long-term monitoring of children with Pseudo Tumor Cerebri Syndrome by transbulbar sonography6
Deepening the understanding of mechanisms of antiepileptic effects of the ketogenic diet in children with AFG2A-related encephalopathy6
Room to improve: The diagnostic journey of Spinal Muscular Atrophy6
Understanding North Star Ambulatory Assessment total scores and their implications for standards of care using observational data6
Neurological and psychiatric phenotype of a multicenter cohort of patients with SETD5-related neurodevelopmental disorder6
Neurologic manifestations in children with COVID-196
Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome6
Clinical and radiological findings of posterior reversible encephalopathy syndrome in children: About 16 children hospitalized in the pediatric department of a Tunisian tertiary care hospital6
The use of intrathecal baclofen for management of spasticity in hereditary spastic paraparesis: A case series6
Melatonin usage in children and young adults, a registry-based cohort study6
Pediatric-onset multiple sclerosis in Greece: A single-center study of the risk factors and a review of the literature5
Approach to childhood tremors: Insights from a pediatric neurologist5
Lesion size and long-term cognitive outcome after pediatric stroke: A comparison between two techniques to assess lesion size5
Phenotypic expansion of EGP5-related Vici syndrome: 15 Dutch patients carrying a founder variant5
Effects of motor imagery adding to physiotherapy and rehabilitation program in children with Duchenne Muscular Dystrophy: does it make a difference?5
Outcome of herpes simplex virus encephalitis in children and young people5
Deep Brain Stimulation in childhood-onset dystonia due to brain pathology. A long-term study5
Brain morphometry and psychomotor development in children with PCH2A5
The long-term burden of congenital cytomegalovirus: Hospitalisation and mortality in a population-based matched cohort study5
Identification of PMD subgroups using a myelination score for PMD5
Monocentric retrospective clinical outcome in a group of 13 patients with opsoclonus myoclonus syndrome, proposal of diagnostic algorithm and review of the literature5
Reassuring neuropsychological outcome data in myelin oligodendrocyte glycoprotein antibody-associated disease5
Cognitive development after perinatal unilateral infarctions: No evidence for preferential sparing of verbal functions5
Editorial Board5
Prednisolone or tetracosactide depot for infantile epileptic spasms syndrome? A prospective analysis of data embedded within two randomised controlled trials5
Impact of lesion metrics and neurological functions on long-term cognitive outcome in childhood stroke5
Education and participation in children and adolescents with Duchenne muscular dystrophy in Switzerland5
Dystonia following acquired brain injury (ABI) in childhood – Not as common as we might think?5
Serum Neurofilament light chain (NfL) levels in children with and without neurologic diseases5
Mitochondrial encephalopathies and myopathies: Our tertiary center's experience5
Transcranial magnetic stimulation in children with fetal alcohol spectrum disorder: A randomised, crossover pilot-trial5
Unravelling key pathways in childhood ataxia to guide diagnosis and treatment5
Corrigendum to “Pediatric SMA patients with complex spinal anatomy: Implementation and evaluation of a decision-tree algorithm for administration of nusinersen”[ Eur. J. Paediatr. Neurol. (2021) 92–105
0.67785882949829